PB
Invesco Biotechnology & Genome ETF (PBE)
NYSE
94.83
+0.13 (+0.14%)
Real-time Data
01:30 PM
Day's Range
93.8495.84
52 wk Range
70.0198.82
Overview - PBE - Invesco Biotechnology & Genome ETF
Key Statistics
Valuation
P/E (Trailing)
‪26.14‬
Price stats
50-Day Avg
‪94.09‬
200-Day Avg
‪85.22‬
Dividends
Frequency
Annual
Market Cap - PBE - Invesco Biotechnology & Genome ETF
Peers - PBE - Invesco Biotechnology & Genome ETF
Peer Comparison
Compared with other ETFs.
- PBPBENYSEInvesco Biotechnology & Genome ETF363.17MMarket Cap+28.90%52-week change26.14P/E (Trailing)—Profit Margin
- IVVNYSEiShares Core S&P 500 ETF446.58BMarket Cap+12.70%52-week change24.86P/E (Trailing)—Profit Margin
- FIFIYYNYSEGraniteShares YieldBOOST 20Y+ Treasuries ETF241.84BMarket Cap-6.46%52-week change—P/E (Trailing)—Profit Margin
- IWIWFNYSEiShares Russell 1000 Growth ETF135.91BMarket Cap+6.96%52-week change30.56P/E (Trailing)—Profit Margin
- GLGLDNYSESPDR Gold Shares112.77BMarket Cap+4.15%52-week change—P/E (Trailing)—Profit Margin
- EFEFANYSEiShares MSCI EAFE ETF95.13BMarket Cap+8.33%52-week change17.86P/E (Trailing)—Profit Margin
- IEMGNYSEiShares Core MSCI Emerging Markets ETF89.95BMarket Cap+18.39%52-week change14.44P/E (Trailing)—Profit Margin
Profile Summary - PBE - Invesco Biotechnology & Genome ETF
About
Invesco Biotechnology & Genome ETF is an exchange-traded fund that targets U.S. biotechnology and genome companies, using the Dynamic Biotech & Genome Intellidex as its benchmark. The fund generally invests at least 90% of its assets in common stocks of companies included in the index, with holdings centered on…
Employees0
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
